Colorectal cancer is quietly getting younger, and Georgia is feeling it. New research out of Augusta University finds that colon and rectal cancers are rising in people under 50, while younger patients in the state are more likely to face treatment delays, uneven care and survival gaps that track with race, sex and ZIP code. The work, led by Dr. Meng‑Han Tsai at the Georgia Prevention Institute, pairs Georgia cancer‑registry data with national analyses to show that the disease is not just becoming more common, it is landing hardest on specific communities.
“Early‑onset colorectal cancer is no longer rare,” Tsai said after leading a series of studies focused on patients diagnosed before age 50, as detailed by Augusta University. Her Georgia analysis, published in Am J Cancer Res, found that men, especially those ages 30 to 39, had significantly lower one‑, three‑ and five‑year survival than women. The same work documented widespread lags to care, with many younger patients waiting more than 90 days to start treatment.
Those local findings line up with the national picture. A new review from the American Cancer Society reports that colorectal cancer incidence and deaths have climbed among younger Americans, with the increase concentrated in the distal colon and rectum. According to its Colorectal Cancer Statistics, 2026 report, the shift has injected new urgency into screening and research, and the U.S. Preventive Services Task Force now recommends that routine colorectal cancer screening start at age 45, per the updated guidance from the USPSTF.
A separate time‑trend study using Georgia Cancer Registry records found that early‑onset cases are climbing fastest in Clayton County and in the northeast and southeast regions of the state, suggesting that some communities may need much more targeted outreach and support, according to a state analysis. The authors point to persistent resource gaps and under‑resourced areas as likely drivers of who gets diagnosed early and who runs into roadblocks when they try to get care.
Where Delays and Disparities Show Up
Tsai’s group found that treatment delays and inconsistent care sit at the center of the outcome gap. Many younger patients waited months before starting therapy, and those holdups were more common among men and among racial and ethnic minority groups. The research also shows that patients who live in rural or persistently poor areas are more likely to die from colorectal cancer even after accounting for tumor features and treatment, a pattern detailed in JAMA Network Open.
What To Watch For and What To Do
Clinicians keep coming back to two straightforward points: if you are 45 or older, get screened; if you are younger and have persistent symptoms such as rectal bleeding, a lasting change in bowel habits or unexplained weight loss, push for a prompt workup rather than letting it slide. The USPSTF recommendation to begin screening at 45 is now the standard, and programs that automatically mail stool‑based FIT test kits have already shown they can bump up screening rates in newly eligible 45‑ to 49‑year‑olds. For symptom checklists and explanations of screening options, the CDC lays out the basics, and UCLA Health summarizes a JAMA trial showing that mailed FIT outreach substantially improves screening uptake.
Tsai and her co‑authors stress that fixing the problem will take more than better chemotherapy regimens. Improving survival for early‑onset colorectal cancer, they argue, will require earlier detection and concrete action on the social and health‑system barriers that slow diagnosis and treatment. “Access isn’t just about distance,” Tsai warned, urging policymakers and health systems to speed referrals, expand screening access and close the gaps that leave young adults waiting when time matters most.
